ES2177584T3 - Composicion de prostaglandinas transdermica. - Google Patents

Composicion de prostaglandinas transdermica.

Info

Publication number
ES2177584T3
ES2177584T3 ES94931344T ES94931344T ES2177584T3 ES 2177584 T3 ES2177584 T3 ES 2177584T3 ES 94931344 T ES94931344 T ES 94931344T ES 94931344 T ES94931344 T ES 94931344T ES 2177584 T3 ES2177584 T3 ES 2177584T3
Authority
ES
Spain
Prior art keywords
transdermica
prostaglandinas
composition
polyisobutilene
transdermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931344T
Other languages
English (en)
Inventor
Hanns A Wendel
Franz-Josef Braun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of ES2177584T3 publication Critical patent/ES2177584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACIONES DE MEDICINA TRANSDERMICA QUE CONTIENEN PROSTAGLANDINA, OPCIONALMENTE UN EXCIPIENTE LIPOFILICO, Y UN ADHESIVO SENSITIVO A LA PRESION DE POLIISOBUTILENO.
ES94931344T 1993-11-19 1994-10-11 Composicion de prostaglandinas transdermica. Expired - Lifetime ES2177584T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/155,126 US5380760A (en) 1993-11-19 1993-11-19 Transdermal prostaglandin composition

Publications (1)

Publication Number Publication Date
ES2177584T3 true ES2177584T3 (es) 2002-12-16

Family

ID=22554196

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931344T Expired - Lifetime ES2177584T3 (es) 1993-11-19 1994-10-11 Composicion de prostaglandinas transdermica.

Country Status (6)

Country Link
US (2) US5380760A (es)
EP (1) EP0729358B1 (es)
JP (1) JPH09505289A (es)
DE (1) DE69431209T2 (es)
ES (1) ES2177584T3 (es)
WO (1) WO1995013816A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133334A1 (en) * 1993-02-03 1994-08-04 Atsuo Hazato External skin treatment agent composition containing prostacyclins as active ingredient
DE69526437T2 (de) * 1994-05-18 2002-10-31 Hisamitsu Pharmaceutical Co., Inc. Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6241998B1 (en) 1999-02-02 2001-06-05 Acutek International Dermatological patch
US7083781B2 (en) * 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) * 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
KR100402334B1 (ko) 2000-06-23 2003-10-22 환인제약 주식회사 알프로스타딜 외용제
US6673841B2 (en) 2001-12-20 2004-01-06 Whan In Pharm. Co., Ltd. Alprostadil alkyl ester-containing composition for external application
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
WO2004112724A2 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
EP1878429B1 (en) * 2005-04-28 2011-08-03 Ono Pharmaceutical Co., Ltd. Trenadermal absorption preparation
CA2611224C (en) * 2005-06-10 2014-01-21 3M Innovative Properties Company Method for handling adhesive laminate sections
US20100256568A1 (en) * 2005-06-27 2010-10-07 Frederickson Franklyn L Microneedle cartridge assembly and method of applying
CA2657435A1 (en) 2006-07-10 2008-07-03 Medipacs, Inc. Super elastic epoxy hydrogel
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
EP2790684B1 (en) 2011-12-16 2016-10-12 3M Innovative Properties Company Foldable adhesive composite dressing
BR112014014828A2 (pt) 2011-12-21 2017-06-13 3M Innovative Properties Co conjunto de emplastros adesivos com revestimento de sobreposição e sistema e método para a produção do mesmo
US9144671B2 (en) 2011-12-21 2015-09-29 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
ITRM20120036A1 (it) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare.
JP2015510956A (ja) 2012-03-14 2015-04-13 メディパックス インコーポレイテッド 過剰反応性分子を含むスマートポリマー材料
WO2014059104A1 (en) 2012-10-10 2014-04-17 3M Innovative Properties Company Applicator and method for applying a microneedle device to skin
WO2014078545A1 (en) 2012-11-16 2014-05-22 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
NO2753788T3 (es) * 2013-05-10 2018-06-16
KR102274902B1 (ko) 2013-05-31 2021-07-07 쓰리엠 이노베이티브 프로퍼티즈 컴파니 마이크로니들 주사 및 주입 장치 및 그의 사용 방법
JP6494602B2 (ja) 2013-05-31 2019-04-03 スリーエム イノベイティブ プロパティズ カンパニー 二重カバーを備えるマイクロニードル注射装置
ES2686362T3 (es) 2013-05-31 2018-10-17 3M Innovative Properties Company Aparato de inyección de microagujas que comprende una accionador inverso
WO2016099986A2 (en) 2014-12-18 2016-06-23 3M Innovative Properties Company Methods of handling adhesive laminate patches
US20210100754A1 (en) 2016-02-05 2021-04-08 3M Innovative Properties Company Transdermal drug delivery systems with fluorosilicone release liners
DE102019120403A1 (de) * 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US4103026A (en) * 1976-08-23 1978-07-25 Carlson Lars A Treatment of peripheral vascular disease by non-intraarterial administration of prostaglandin E1
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
JPS5948409A (ja) * 1982-09-10 1984-03-19 Teikoku Seiyaku Kk 矯正的歯牙移動促進剤
US4515810A (en) * 1983-10-06 1985-05-07 American Cyanamid Company Composition of matter
JPS6185315A (ja) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk シ−ト状製剤
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
JPS63135333A (ja) * 1986-11-26 1988-06-07 Nitto Electric Ind Co Ltd プロスタグランジン類含有貼付剤
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
JPH0676321B2 (ja) * 1987-02-18 1994-09-28 久光製薬株式会社 クロニジン経皮投与製剤
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
JP2910857B2 (ja) * 1989-04-04 1999-06-23 ニチバン株式会社 プロスタグランジンｅ１経皮吸収製剤
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3568966B2 (ja) * 1992-03-31 2004-09-22 久光製薬株式会社 クロニジン経皮投与製剤

Also Published As

Publication number Publication date
US5480648A (en) 1996-01-02
EP0729358B1 (en) 2002-08-21
DE69431209D1 (de) 2002-09-26
DE69431209T2 (de) 2003-04-17
EP0729358A1 (en) 1996-09-04
WO1995013816A1 (en) 1995-05-26
US5380760A (en) 1995-01-10
JPH09505289A (ja) 1997-05-27

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2172572T3 (es) Emulsion farmaceutica.
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
MX9201082A (es) Procedimiento para la preparacion de una composicion farmaceutica que comprende gases propelentes libres de cloro.
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
MX9307686A (es) Preparacion de liberacion sostenida.
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
FI955124L (fi) Protonipumppuinhibiittorin sisältävä eläinlääkeseos
ES267310Y (es) "un dispositivo para aplicar presion compresora a una extremidad de un paciente".
ES2171710T3 (es) Emplastos con hormonas.
CO4750836A1 (es) Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
ATE46080T1 (de) Pharmazeutische komposition.
MX9202804A (es) Composicion farmaceutica y terapeutica que comprende una nueva molecula de adhesion intracelular.
TR199700726T1 (xx) Farnezil transferaz �nleyiciler ve m�stahzarlar�.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ES2114157T3 (es) Copolimeros de (met)acriloxi-alquil-siloxisilano y alquil(met)acrilatos y su uso como adhesivos sensibles a la presion.
ES2100046T3 (es) Composiciones antipireticas y analgesicas que contienen r-ketorolaco opticamente puro.
DE69224319D1 (de) Photohärtbare Folienklebstoffe
ATE169215T1 (de) Atovaquon enthaltende arzneizubereitungen
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
ES2068350T3 (es) Acidos oxoftalazinilaceticos sustituidos y analogos de los mismos.
ES2090066T3 (es) Preparaciones externas que contienen agua y propionato de deprodona.